The HKAPI Regulatory Working Group recently held a forum for its members to exchange views on regulatory intelligence. Around 60 members attended the event.
The Hong Kong Association of the Pharmaceutical Industry (HKAPI) is delighted to be one of the supporting organizations of the hybrid event hosted by InvestHK - “The Journey of Biotech Innovation and Investment in Hong Kong” on 7 July.
To help HKAPI members understand more about the operation of DHC and opportunities for the pharmaceutical industry, the Public-Private Partnership task force organized a Sharing Session on April 27, 2022.